Time-Restricted Eating in Alzheimer’s Disease: The T.R.E.A.D trial
The purpose of the study is to assess the feasibility and impact of time-restricted eating on cognitive performance and blood biomarkers of metabolic health in adults with mild cognitive impairment. We will collect characteristics that are associated with cognitive function and cognitive decline (e.g. emotional, behavioral, and lifestyle factors). The information we collect will be used to characterize the population to better understand how the characteristics such as engagement in a time-restricted dietary intervention will be related to cognitive performance and emotional health. In the future, the information we gain from the data will be used to perform interventions and workshops to promote cognitive and emotional health.
Who can Participate
Patients who are generally in good health and have been diagnosed with mild cognitive impairment (MCI) are invited to participate in the study.
The study will consist of two in-clinic screening visits, each lasting approximately 4.5 to 5 hours. The entire process will be completed within a span of 2 weeks. The screening visit will be followed by a 3 month follow-up in-clinic visit that will complete the study. The approximate duration of the end of study visit will be 3.5 hours.